Abstract:Protein modification by ubiquitin fold modifier 1 (UFM1), termed ufmylation, regulates various physiological and pathological processes. Among emerging UFM1 targets, UFM1 binding protein 1 (UFBP1) is the first identified ufmylation substrate. Recent clinical and animal studies have demonstrated the pivotal roles of UFBP1 in development, hematopoiesis, intestinal homeostasis, chondrogenesis, and neuronal development, which has been linked to its function in maintaining endoplasmic reticulum (ER) homeostasis. However, the importance of UFBP1 ufmylation in these cellular and physiological processes has yet to be determined. It has been proposed that ufmylation of lysine 268 (267 in humans) in UFBP1 plays a critical role in mediating the effects of the ufmylation pathway. In this study, we for the first time probe the pathophysiological significance of UFBP1 ufmylation in vivo by creating and characterizing a mouse UFBP1 knockin (KI) model in which the lysine 268 of UFBP1, the amino acid accepting UFM1, was mutated to arginine. Our results showed that the K268R mutation reduced the total ufmylated proteins without altering the expression levels of individual ufmylation enzymes in mouse embryonic fibroblasts. The K268R mutation did not alter ER stress–stimuli–induced ER stress signaling or cell death in mouse embryonic fibroblasts. The homozygous KI mice were viable and morphologically indistinguishable from their littermate wild–type controls up to one year of age. Serial echocardiography revealed no cardiac functional impairment of the homozygous KI mice. Furthermore, the homozygous KI mice exhibited the same susceptibility to dextran sulfate sodium (DSS) –induced colitis as wild-type mice. Taken together, these results suggest that UFBP1 K268 is dispensable for ER stress response, embryonic development, cardiac homeostasis under physiological conditions, and intestinal homeostasis under pathological conditions. Our studies call for future investigations to understand the biological function of UFBP1 ufmylation and offer a new mouse model to determine the roles of UFBP1 ufmylation in different tissues under stress conditions.

The Post-Translational Role of UFMylation in Physiology and Disease

UFMylation: An integral post-translational modification for the regulation of proteostasis and cellular functions

A guide to UFMylation, an emerging posttranslational modification

UFMylation: a ubiquitin-like modification

UFMylation System: an Emerging Player in Tumorigenesis

The emerging roles of UFMylation in the modulation of immune responses

Emerging role of UFMylation in secretory cells involved in the endocrine system by maintaining ER proteostasis

Role of UFMylation in tumorigenesis and cancer immunotherapy

The UFM1 system: Working principles, cellular functions, and pathophysiology

UFL1, a UFMylation E3 Ligase, Plays a Crucial Role in Multiple Cellular Stress Responses

Nontraditional translation is the key to UFMylation and beyond.

Proteomic and Biochemical Analyses Reveal a Novel Mechanism for Promoting Protein Ubiquitination and Degradation by UFBP1, a Key Component of Ufmylation.

Essential Role of Ufm1 Conjugation in the Hematopoietic System

Ufmylation of UFBP1 Is Dispensable for Endoplasmic Reticulum Stress Response, Embryonic Development, and Cardiac and Intestinal Homeostasis

Mechanistic insights into the roles of the UFM1 E3 ligase complex in ufmylation and ribosome-associated protein quality control

UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination

Structural study of UFL1-UFC1 interaction uncovers the role of UFL1 N-terminal helix in ufmylation

UFMylation of HRD1 regulates endoplasmic reticulum homeostasis

The role of ubiquitination in health and disease

The emerging roles of ubiquitin-like protein Urm1 in eukaryotes

Roles of post-translational modifications of UHRF1 in cancer